Replies to post #75555 on Muscle Pharm Corporation (MSLPQ)

[Deep Space]

If they turn it around I will blame Cory..:)

1.Yeah,ok-Still need more than natural light to get more honeys in here. They need a higher price? Ive been screaming that for years.:) Go get it guys.

2.It does appear they are working with MP right now and the filing says so but maybe Brads share sales had something to do with them? How much deeper will the bank go? I am thinking a capital raise with language that will take LC on the case to figure out.

3.I take no comfort in accounting Loss.The fundamentals are always moving around here and the expenses keep coming and the payday for insiders. I personally don't trust the cost of revenue number and it doesn't matter when the real costs keep keep keep knocking it down. Maybe 1q margins was reason for inventory depletion and won't last.

4. I appreciate that number and don't know how to gauge it's worth. The market is not impressed yet and I can trust it doesn't have full faith in a crunch bar marketing bonanza.

They put the pressure on now and will be interesting.

[CWS1987]

But if it's being held in true escrow, ANB wouldn't be able to sell the shares, so I wouldn't put too much faith in them having not dumped the position yet. That said, I don't think they would do that unless the company really skids in Q2 and cash flow gets so bad that they can't pay their producers.

I'll preference this by saying that I'm generally biased against non-GAAP measures. However, in the case of MSLP, I think that bias is very justified. The non-GAAP EBITDA figure is a particularly bad metric for analysis the stock's potential, because the company is actively diluting. In addition to the excessive, stock-based executive compensation, they paid for the Coco Protein production and clothing rights in part by issuing something like 300,000 new shares. For the company to then turn around and say, "But if we ignore that dilution, our losses are smaller than they look." is disingenuous and misleading.